Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

African Medicines Agency To Be Established In 2022

Host Country Sought For New Body

Executive Summary

Enough African countries have now ratified the AMA treaty to allow it to come into force next month.

You may also be interested in...



New Alliance Urges Countries To Ratify Treaty On African Medicines Agency

Stakeholders are making a concerted effort to get the new agency off the ground, saying it will not only reduce drug approval times but help to drive industrial and economic growth in Africa. The European Medicines Agency is offering to share its experience in regulatory collaboration and network building.

African Countries Urged To Back New Medicines Agency

COVID-19 has highlighted the need for greater harmonization of medicines regulation to tackle health issues and emergencies more effectively in Africa. With that in mind, countries are being encouraged to speed up their ratification of a treaty setting up a new pan-African body tasked with coordinating national regulatory efforts, improving access to quality medicines and supporting the local pharmaceutical industry.

Lenzilumab & Evusheld Make It Onto EU List Of ‘Most Promising’ COVID-19 Treatments

Two products that were on the European Commission’s original list of the “top five” COVID-19 candidate therapeutics in development have been dropped from the latest “top 10” portfolio.

Topics

UsernamePublicRestriction

Register

PS145076

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel